Research published online in BMJ Open reveals that the NHS paid an extra £625 million on synthetic forms of insulin over the past decade, when the considerably cheaper recommended human alternatives would have probably been just as effective.
The NHS paid an extra £625 million on synthetic insulin over the past decade